Mubasher: Dar Al Shifa Pharmaceuticals reported a 50.8% decline in profits in the second quarter of 2016 to $282,140, compared to $573,400 in the same period last year.
Profits also decreased 1.7% year-on-year in H1-16 to $1.76 million, from $1.79 million in H1-15, according to the company’s statement to The Palestine Exchange (PEX).
